ArticleDrug and alcohol review2025
Understanding Drug and Alcohol Staff Perspectives on the Barriers and Facilitators to Drug Checking: A Qualitative Study.
Article in Drug and alcohol review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Interpol review of forensic drug chemistry, 2022-2025.Forensic science international. Synergy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionDrug checking (i.e., whereby members of the public submit a drug sample for pharmacological analysis of the drug content) is an evidence-based harm reduction tool. Despite this, the uptake of drug checking services by people who use drugs (PWUD) is often limited across different jurisdictions and types of services, highlighting the need for research examining barriers to drug checking uptake from the perspective of key stakeholders. This qualitative pre-implementation study explored the perspectives of staff employed by alcohol and other drug (AOD) organisations on drug checking, including barriers and facilitators to uptake.
methodsInterviews were conducted with 23 AOD harm reduction and AOD treatment staff (14 female; mean age = 38.8 years, SD = 8.2). Qualitative data were analysed using iterative categorisation.
resultsFive themes were extracted from the data: (i) PWUD infrequently are most likely to access drug checking; (ii) Confidentiality and anonymity concerns are barriers to drug checking; (iii) Ease of use is integral to drug checking uptake; (iv) Safe, non-judgemental environments that include peer workers are critical; and (v) People who sell drugs will likely use drug checking. DISCUSSION AND
conclusionsThe following factors were identified as paramount to the uptake of drug checking services among PWUD: (i) confidentiality; (ii) agreements or memoranda of understanding that protect service clients from over-policing and criminalisation; (iii) mobile and fixed-site services that are accessible to PWUD; and (iv) a non-judgemental and safe environment that includes both health professionals and peer workers with lived experience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.